{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T15:50:11Z","timestamp":1782229811103,"version":"3.54.5"},"reference-count":82,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurosurgery Clinics of North America"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.nec.2026.02.006","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:23:13Z","timestamp":1775780593000},"page":"377-387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intramedullary Spinal Cord Tumors Associated with the Neurofibromatoses"],"prefix":"10.1016","volume":"37","author":[{"given":"Jesse A.","family":"Stokum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan J.","family":"Belzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaishri O.","family":"Blakeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.nec.2026.02.006_bib1","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.nec.2026.02.006_bib2","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/neuonc\/nov200","article-title":"Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis","volume":"18","author":"Blakeley","year":"2016","journal-title":"Neuro Oncol"},{"issue":"5","key":"10.1016\/j.nec.2026.02.006_bib3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1055\/s-0035-1549029","article-title":"Intramedullary spinal cord tumors: part i-epidemiology, pathophysiology, and diagnosis","volume":"5","author":"Samartzis","year":"2015","journal-title":"Glob Spine J"},{"issue":"4","key":"10.1016\/j.nec.2026.02.006_bib4","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1148\/rg.2020190196","article-title":"Intramedullary masses of the spinal cord: radiologic-pathologic correlation","volume":"40","author":"Shih","year":"2020","journal-title":"Radiographics"},{"issue":"1","key":"10.1016\/j.nec.2026.02.006_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1023\/B:NEON.0000024747.66993.26","article-title":"Spinal cord gangliogliomas: a review of 56 patients","volume":"68","author":"Jallo","year":"2004","journal-title":"J Neuro Oncol"},{"issue":"22","key":"10.1016\/j.nec.2026.02.006_bib6","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1002\/cncr.26181","article-title":"Clinical course of adult patients with ependymoma: results of the adult ependymoma outcomes project","volume":"117","author":"Armstrong","year":"2011","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.nec.2026.02.006_bib7","doi-asserted-by":"crossref","first-page":"e531","DOI":"10.1097\/BPO.0000000000002431","article-title":"Consensus-based best practice guidelines for the management of spinal deformity and associated tumors in pediatric neurofibromatosis type 1: screening and surveillance, surgical intervention, and medical therapy","volume":"43","author":"Xu","year":"2023","journal-title":"J Pediatr Orthop"},{"issue":"2","key":"10.1016\/j.nec.2026.02.006_bib8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00256-019-03290-1","article-title":"Current status and recommendations for imaging in neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis","volume":"49","author":"Ahlawat","year":"2020","journal-title":"Skelet Radiol"},{"issue":"11","key":"10.1016\/j.nec.2026.02.006_bib9","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1093\/neuonc\/noac146","article-title":"Management of neurofibromatosis type 1-associated plexiform neurofibromas","volume":"24","author":"Fisher","year":"2022","journal-title":"Neuro Oncol"},{"issue":"6","key":"10.1016\/j.nec.2026.02.006_bib10","first-page":"1279","article-title":"Intramedullary spinal ependymomas: analysis of a consecutive series of 82 adult cases with particular attention to patients with no preoperative neurological deficit","volume":"62","author":"Aghakhani","year":"2008","journal-title":"Neurosurgery"},{"issue":"3","key":"10.1016\/j.nec.2026.02.006_bib11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3171\/jns.1981.54.3.0323","article-title":"Long-term results of the surgical treatment of 129 intramedullary spinal gliomas","volume":"54","author":"Guidetti","year":"1981","journal-title":"J Neurosurg"},{"issue":"5","key":"10.1016\/j.nec.2026.02.006_bib12","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1227\/00006123-199411000-00010","article-title":"Surgical results of 100 intramedullary tumors in relation to accompanying syringomyelia","volume":"35","author":"Samii","year":"1994","journal-title":"Neurosurgery"},{"issue":"22 Suppl","key":"10.1016\/j.nec.2026.02.006_bib13","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1097\/BRS.0b013e3181b95c6f","article-title":"Primary intramedullary tumors of the spinal cord","volume":"34","author":"Harrop","year":"2009","journal-title":"Spine"},{"issue":"2","key":"10.1016\/j.nec.2026.02.006_bib14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ajmg.a.33139","article-title":"Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service","volume":"152A","author":"Evans","year":"2010","journal-title":"Am J Med Genet"},{"issue":"9","key":"10.1016\/j.nec.2026.02.006_bib15","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/gim.2017.215","article-title":"Prevalence of neurofibromatosis type 1 in the Finnish population","volume":"20","author":"Kallionpaa","year":"2018","journal-title":"Genet Med"},{"issue":"27","key":"10.1016\/j.nec.2026.02.006_bib16","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2506823122","article-title":"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system","volume":"122","author":"Vasudevan","year":"2025","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.nec.2026.02.006_bib17","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/1098-1004(200006)15:6<541::AID-HUMU6>3.0.CO;2-N","article-title":"Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects","volume":"15","author":"Messiaen","year":"2000","journal-title":"Hum Mutat"},{"issue":"6","key":"10.1016\/j.nec.2026.02.006_bib18","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1136\/jmg.40.6.e82","article-title":"Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients","volume":"40","author":"Ars","year":"2003","journal-title":"J Med Genet"},{"issue":"6","key":"10.1016\/j.nec.2026.02.006_bib19","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.mcna.2019.07.004","article-title":"The diagnosis and management of neurofibromatosis type 1","volume":"103","author":"Ly","year":"2019","journal-title":"Med Clin North Am"},{"issue":"11","key":"10.1016\/j.nec.2026.02.006_bib20","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1212\/WNL.56.11.1433","article-title":"The clinical and diagnostic implications of mosaicism in the neurofibromatoses","volume":"56","author":"Ruggieri","year":"2001","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.nec.2026.02.006_bib21","first-page":"155","article-title":"Academic achievement of children with neurofibromatosis type 1","author":"Hou","year":"2025","journal-title":"Pediatrics"},{"issue":"9\u201310","key":"10.1016\/j.nec.2026.02.006_bib22","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1101\/gad.352629.125","article-title":"Cognition and behavior in neurofibromatosis type 1: report and perspective from the cognition and behavior in NF1 (CABIN) task force","volume":"39","author":"Gutmann","year":"2025","journal-title":"Genes Dev"},{"issue":"6","key":"10.1016\/j.nec.2026.02.006_bib23","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/mus.26687","article-title":"Evidence of small-fiber neuropathy in neurofibromatosis type 1","volume":"60","author":"Barnett","year":"2019","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.nec.2026.02.006_bib24","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1177\/0883073812448531","article-title":"Spectrum and prevalence of vasculopathy in pediatric neurofibromatosis type 1","volume":"28","author":"Kaas","year":"2013","journal-title":"J Child Neurol"},{"issue":"3","key":"10.1016\/j.nec.2026.02.006_bib25","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/neuonc\/noae235","article-title":"Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of neurofibromatosis type 1","volume":"27","author":"Lucas","year":"2025","journal-title":"Neuro Oncol"},{"issue":"8","key":"10.1016\/j.nec.2026.02.006_bib26","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","article-title":"Revised diagnostic criteria for neurofibromatosis type 1 and legius syndrome: an international consensus recommendation","volume":"23","author":"Legius","year":"2021","journal-title":"Genet Med"},{"issue":"9","key":"10.1016\/j.nec.2026.02.006_bib27","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1212\/01.wnl.0000250332.89420.e6","article-title":"NF1 plexiform neurofibroma growth rate by volumetric MRI: relationship to age and body weight","volume":"68","author":"Dombi","year":"2007","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.nec.2026.02.006_bib28","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1093\/neuonc\/noaa053","article-title":"Longitudinal evaluation of peripheral nerve sheath tumors in neurofibromatosis type 1: growth analysis of plexiform neurofibromas and distinct nodular lesions","volume":"22","author":"Akshintala","year":"2020","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.nec.2026.02.006_bib29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1634\/theoncologist.2013-0328","article-title":"Malignant peripheral nerve sheath tumors","volume":"19","author":"Farid","year":"2014","journal-title":"Oncologist"},{"issue":"17","key":"10.1016\/j.nec.2026.02.006_bib30","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1038\/s41388-022-02290-1","article-title":"Malignant peripheral nerve sheath tumor: models, biology, and translation","volume":"41","author":"Somatilaka","year":"2022","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.nec.2026.02.006_bib31","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1007\/s00381-020-04754-9","article-title":"Spinal manifestations of neurofibromatosis type 1","volume":"36","author":"Shofty","year":"2020","journal-title":"Childs Nerv Syst"},{"issue":"9","key":"10.1016\/j.nec.2026.02.006_bib32","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s002340050814","article-title":"Spinal tumours in neurofibromatosis type 1: an MRI study of frequency, multiplicity and variety","volume":"41","author":"Thakkar","year":"1999","journal-title":"Neuroradiology"},{"key":"10.1016\/j.nec.2026.02.006_bib33","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/j.wneu.2022.10.100","article-title":"A review of spinal lesions in neurofibromatosis type 1 in a large neurofibromatosis type 1 center","volume":"169","author":"Sial","year":"2023","journal-title":"World Neurosurg"},{"issue":"5","key":"10.1016\/j.nec.2026.02.006_bib34","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/cge.12498","article-title":"The natural history of spinal neurofibromatosis: a critical review of clinical and genetic features","volume":"87","author":"Ruggieri","year":"2015","journal-title":"Clin Genet"},{"issue":"11","key":"10.1016\/j.nec.2026.02.006_bib35","doi-asserted-by":"crossref","first-page":"876.e17","DOI":"10.1016\/j.crad.2020.05.010","article-title":"Intramedullary tumours and tumour mimics","volume":"75","author":"Kandemirli","year":"2020","journal-title":"Clin Radiol"},{"issue":"5","key":"10.1016\/j.nec.2026.02.006_bib36","first-page":"972","article-title":"Long-term follow-up of intramedullary spinal cord tumors: a series of 202 cases","volume":"56","author":"Raco","year":"2005","journal-title":"Neurosurgery"},{"issue":"6","key":"10.1016\/j.nec.2026.02.006_bib37","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.radcr.2020.02.033","article-title":"Unexpected discovery of a diffuse astrocytoma of the conus medullaris in an elderly NF1 patient","volume":"15","author":"Uchi","year":"2020","journal-title":"Radiol Case Reports"},{"issue":"11","key":"10.1016\/j.nec.2026.02.006_bib38","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/BF01411560","article-title":"Intramedullary spinal cord tumour associated with neurofibromatosis type 1","volume":"139","author":"Yagi","year":"1997","journal-title":"Acta Neurochir (Wien)"},{"issue":"4","key":"10.1016\/j.nec.2026.02.006_bib39","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00234-007-0345-7","article-title":"Intradural spinal tumors: current classification and MRI features","volume":"50","author":"Abul-Kasim","year":"2008","journal-title":"Neuroradiology"},{"issue":"6","key":"10.1016\/j.nec.2026.02.006_bib40","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3171\/2014.1.PEDS13316","article-title":"Long-term disease and neurological outcomes in patients with pediatric intramedullary spinal cord tumors","volume":"13","author":"Ahmed","year":"2014","journal-title":"J Neurosurg Pediatr"},{"issue":"3","key":"10.1016\/j.nec.2026.02.006_bib41","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s11060-013-1251-y","article-title":"Risk factors and long-term survival in adult patients with primary malignant spinal cord astrocytomas","volume":"115","author":"Wong","year":"2013","journal-title":"J Neuro Oncol"},{"issue":"4","key":"10.1016\/j.nec.2026.02.006_bib42","doi-asserted-by":"crossref","first-page":"201","DOI":"10.5414\/NP301314","article-title":"Malignant transformation of NF1-associated spinal astrocytoma with loss of ATRX expression during the course: a case report","volume":"40","author":"Yuzawa","year":"2021","journal-title":"Clin Neuropathol"},{"issue":"16","key":"10.1016\/j.nec.2026.02.006_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16162781","article-title":"The role of radiotherapy, chemotherapy, and targeted therapies in adult intramedullary spinal cord tumors","volume":"16","author":"Esparragosa Vazquez","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.nec.2026.02.006_bib44","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1159\/000449406","article-title":"Single-agent carboplatin for a rare case of pilomyxoid astrocytoma of the spinal cord in an adult with neurofibromatosis type 1","volume":"9","author":"Dunn-Pirio","year":"2016","journal-title":"Case Rep Oncol"},{"issue":"10","key":"10.1016\/j.nec.2026.02.006_bib45","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1007\/s00381-024-06430-8","article-title":"Low-grade glioma in children with neurofibromatosis type 1: surveillance, treatment indications, management, and future directions","volume":"40","author":"Kotch","year":"2024","journal-title":"Childs Nerv Syst"},{"issue":"32","key":"10.1016\/j.nec.2026.02.006_bib46","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1200\/JCO.19.00114","article-title":"Subsequent neoplasms after a primary tumor in individuals with neurofibromatosis type 1","volume":"37","author":"Bhatia","year":"2019","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.nec.2026.02.006_bib47","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1097\/00006123-199712000-00038","article-title":"Ganglioglioma of the spinal cord: report of two rare cases and review of the literature","volume":"41","author":"Hamburger","year":"1997","journal-title":"Neurosurgery"},{"issue":"1","key":"10.1016\/j.nec.2026.02.006_bib48","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000355249","article-title":"Ganglioglioma of the spinal cord in neurofibromatosis type 1","volume":"49","author":"Giussani","year":"2013","journal-title":"Pediatr Neurosurg"},{"issue":"3","key":"10.1016\/j.nec.2026.02.006_bib49","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000331569","article-title":"Ganglioglioma of the thoracolumbar spinal cord in a patient with neurofibromatosis type 1: a case report and literature review","volume":"47","author":"Hayashi","year":"2011","journal-title":"Pediatr Neurosurg"},{"issue":"7","key":"10.1016\/j.nec.2026.02.006_bib50","doi-asserted-by":"crossref","first-page":"e979","DOI":"10.1097\/MPH.0000000000002035","article-title":"Multiple intraspinal gangliogliomas in a child with neurofibromatosis type 1: case report and literature review","volume":"43","author":"Morales","year":"2021","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"10.1016\/j.nec.2026.02.006_bib51","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4103\/1793-5482.145088","article-title":"Ganglioglioma of conus medullaris in a patient of neurofibromatosis type 1: a novel association?","volume":"11","author":"Sundar","year":"2016","journal-title":"Asian J Neurosurg"},{"issue":"3","key":"10.1016\/j.nec.2026.02.006_bib52","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1399-0004.2009.01292.x","article-title":"Multiple spinal ganglioneuromas in a patient harboring a pathogenic NF1 mutation","volume":"77","author":"Bacci","year":"2010","journal-title":"Clin Genet"},{"issue":"1","key":"10.1016\/j.nec.2026.02.006_bib53","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40478-018-0551-z","article-title":"The genetic landscape of ganglioglioma","volume":"6","author":"Pekmezci","year":"2018","journal-title":"Acta Neuropathol Commun"},{"issue":"5","key":"10.1016\/j.nec.2026.02.006_bib54","first-page":"879","article-title":"MR of spinal cord ganglioglioma","volume":"19","author":"Patel","year":"1998","journal-title":"AJNR Am J Neuroradiol"},{"issue":"6","key":"10.1016\/j.nec.2026.02.006_bib55","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3171\/jns.1993.79.6.0867","article-title":"Central nervous system gangliogliomas. Part 2: clinical outcome","volume":"79","author":"Lang","year":"1993","journal-title":"J Neurosurg"},{"issue":"2","key":"10.1016\/j.nec.2026.02.006_bib56","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF01050216","article-title":"Gangliogliomas: a clinicopathological study of 25 cases and review of the literature","volume":"17","author":"Krouwer","year":"1993","journal-title":"J Neuro Oncol"},{"issue":"11","key":"10.1016\/j.nec.2026.02.006_bib57","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1002\/1097-0142(19940601)73:11<2862::AID-CNCR2820731133>3.0.CO;2-5","article-title":"Malignant transformation in a ganglioglioma with anaplastic neuronal and astrocytic components. Report of a case with flow cytometric and cytogenetic analysis","volume":"73","author":"Jay","year":"1994","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.nec.2026.02.006_bib58","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/00006123-199805000-00049","article-title":"Radiation therapy and malignant degeneration of benign supratentorial gangliogliomas","volume":"42","author":"Rumana","year":"1998","journal-title":"Neurosurgery"},{"issue":"2","key":"10.1016\/j.nec.2026.02.006_bib59","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/02688697.2020.1836323","article-title":"What to know about schwannomatosis: a literature review","volume":"36","author":"Schraepen","year":"2022","journal-title":"Br J Neurosurg"},{"issue":"1","key":"10.1016\/j.nec.2026.02.006_bib60","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10048-009-0204-2","article-title":"Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation","volume":"11","author":"Bacci","year":"2010","journal-title":"Neurogenetics"},{"issue":"8","key":"10.1016\/j.nec.2026.02.006_bib61","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1158\/1078-0432.CCR-24-3278","article-title":"Update on cancer and central nervous system tumor surveillance in pediatric NF2-SMARCB1-and LZTR1-Related schwannomatosis","volume":"31","author":"Perrino","year":"2025","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nec.2026.02.006_bib62","series-title":"GeneReviews\u00ae [Internet]","article-title":"LZTR1- and SMARCB1-Related Schwannomatosis","author":"Dhamija","year":"1993"},{"issue":"9","key":"10.1016\/j.nec.2026.02.006_bib63","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.gim.2022.05.007","article-title":"Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: an international consensus recommendation","volume":"24","author":"Plotkin","year":"2022","journal-title":"Genet Med"},{"issue":"9","key":"10.1016\/j.nec.2026.02.006_bib64","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jmg-2024-110065","article-title":"NF2-related schwannomatosis and other schwannomatosis: an updated genetic and epidemiological study","volume":"61","author":"Forde","year":"2024","journal-title":"J Med Genet"},{"issue":"12","key":"10.1016\/j.nec.2026.02.006_bib65","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/jmg.29.12.841","article-title":"A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity","volume":"29","author":"Evans","year":"1992","journal-title":"J Med Genet"},{"issue":"4","key":"10.1016\/j.nec.2026.02.006_bib66","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10689-025-00504-5","article-title":"History and clinical epidemiology of NF2-related schwannomatosis","volume":"24","author":"Evans","year":"2025","journal-title":"Fam Cancer"},{"issue":"1","key":"10.1016\/j.nec.2026.02.006_bib67","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41436-019-0598-7","article-title":"Incidence of mosaicism in 1055 de novo NF2 cases: much higher than previous estimates with high utility of next-generation sequencing","volume":"22","author":"Evans","year":"2020","journal-title":"Genet Med"},{"issue":"2","key":"10.1016\/j.nec.2026.02.006_bib68","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/cge.13551","article-title":"Trends in phenotype in the English paediatric neurofibromatosis type 2 cohort stratified by genetic severity","volume":"96","author":"Halliday","year":"2019","journal-title":"Clin Genet"},{"issue":"7","key":"10.1016\/j.nec.2026.02.006_bib69","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/neuonc\/noaa284","article-title":"Disease course of neurofibromatosis type 2: a 30-year follow-up study of 353 patients seen at a single institution","volume":"23","author":"Forde","year":"2021","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1016\/j.nec.2026.02.006_bib70","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11060-010-0339-x","article-title":"Meningiomas and neurofibromatosis","volume":"99","author":"Goutagny","year":"2010","journal-title":"J Neuro Oncol"},{"issue":"5","key":"10.1016\/j.nec.2026.02.006_bib71","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.2214\/ajr.166.5.8615282","article-title":"Spinal tumors in patients with neurofibromatosis type 2: MR imaging study of frequency, multiplicity and variety","volume":"166","author":"Mautner","year":"1996","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.nec.2026.02.006_bib72","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/neuros\/nyx374","article-title":"High-grade glioma is not a feature of neurofibromatosis type 2 in the unirradiated patient","volume":"83","author":"King","year":"2018","journal-title":"Neurosurgery"},{"issue":"24","key":"10.1016\/j.nec.2026.02.006_bib73","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1056\/NEJMoa2400985","article-title":"Brigatinib in NF2-Related schwannomatosis with progressive tumors","volume":"390","author":"Plotkin","year":"2024","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.nec.2026.02.006_bib74","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3171\/2010.11.SPINE10350","article-title":"Spinal ependymomas in neurofibromatosis type 2: a retrospective analysis of 55 patients","volume":"14","author":"Plotkin","year":"2011","journal-title":"J Neurosurg Spine"},{"issue":"2","key":"10.1016\/j.nec.2026.02.006_bib75","doi-asserted-by":"crossref","DOI":"10.3171\/2015.5.FOCUS15158","article-title":"Intramedullary spinal cord tumors: a review of current and future treatment strategies","volume":"39","author":"Tobin","year":"2015","journal-title":"Neurosurg Focus"},{"issue":"3","key":"10.1016\/j.nec.2026.02.006_bib76","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s11060-017-2690-7","article-title":"Spinal ependymomas in NF2: a surgical disease?","volume":"136","author":"Kalamarides","year":"2018","journal-title":"J Neuro Oncol"},{"issue":"4","key":"10.1016\/j.nec.2026.02.006_bib77","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3171\/jns.1990.72.4.0523","article-title":"Intramedullary ependymoma of the spinal cord","volume":"72","author":"McCormick","year":"1990","journal-title":"J Neurosurg"},{"issue":"2","key":"10.1016\/j.nec.2026.02.006_bib78","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jocn.2008.03.005","article-title":"Spinal tumors in neurofibromatosis-2: management considerations - a review","volume":"16","author":"Holland","year":"2009","journal-title":"J Clin Neurosci"},{"issue":"1","key":"10.1016\/j.nec.2026.02.006_bib79","article-title":"Radiation treatment of benign tumors in NF2-related-schwannomatosis: a national study of 266 irradiated patients showing a significant increase in malignancy\/malignant progression","volume":"5","author":"Evans","year":"2023","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.nec.2026.02.006_bib80","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jocn.2021.01.010","article-title":"Bevacizumab as a surgery-sparing agent for spinal ependymoma in patients with neurofibromatosis type II: systematic review and case","volume":"86","author":"Snyder","year":"2021","journal-title":"J Clin Neurosci"},{"issue":"6","key":"10.1016\/j.nec.2026.02.006_bib81","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/ane.12490","article-title":"Bevacizumab treatment for symptomatic spinal ependymomas in neurofibromatosis type 2","volume":"133","author":"Farschtschi","year":"2016","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"10.1016\/j.nec.2026.02.006_bib82","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3171\/2016.8.SPINE16589","article-title":"The response of spinal cord ependymomas to bevacizumab in patients with neurofibromatosis type 2","volume":"26","author":"Morris","year":"2017","journal-title":"J Neurosurg Spine"}],"container-title":["Neurosurgery Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042368026000070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042368026000070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T15:33:18Z","timestamp":1782228798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1042368026000070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":82,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1042368026000070"],"URL":"https:\/\/doi.org\/10.1016\/j.nec.2026.02.006","relation":{},"ISSN":["1042-3680"],"issn-type":[{"value":"1042-3680","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intramedullary Spinal Cord Tumors Associated with the Neurofibromatoses","name":"articletitle","label":"Article Title"},{"value":"Neurosurgery Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nec.2026.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}